A Phase 1b, Open-Label Study Evaluating the Pharmacokinetics and Safety of Miricorilant in Adult Patients With Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Assessment of miricorilant PK parameters
Timeframe: Day 1- Day 4
Assessment of miricorilant PK parameters
Timeframe: Day 1 - Day 4
Assessment of miricorilant PK parameters
Timeframe: Day 1 - Day 4
Assessment of miricorilant PK parameters
Timeframe: Day 1 - Day 4
Assessment of miricorilant PK parameters
Timeframe: Day 1 - Day 4
Assessment of miricorilant PK parameters
Timeframe: Day 1 - Day 4
Assessment of miricorilant PK parameters
Timeframe: Day 1 - Day 4
Assessment of miricorilant PK parameters
Timeframe: Day 1 - Day 4